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Importance: Accurate monitoring of core body temperature is integral to targeted
temperature management (TTM) following cardiac arrest. However, there are no reliable
non-invasive methods for monitoring temperature during TTM.
Objectives: We compared the accuracy and precision of a novel non-invasive ZeroHeat-Flux Thermometer (SpotOnTM ) to a standard invasive esophageal probe in a cohort
of patients undergoing TTM post-cardiac arrest.
Design, Setting, and Participants: We prospectively enrolled 20 patients undergoing
post-cardiac arrest care in the intensive care units at the London Health Sciences Centre
in London, Canada. A SpotOnTM probe was applied on each patient’s forehead, while
an esophageal temperature probe was inserted, and both temperature readings were
recorded at 1-min intervals for the duration of TTM.
Main outcomes and Measures: We compared the SpotOnTM and esophageal
monitors using the Bland–Altman analysis and the Pearson correlation, with accuracy
set as a primary outcome. Secondary outcomes included precision and correlation.
Bias exceeding 0.1◦ C and limits of agreement exceeding 0.5◦ C were considered
clinically important.
Results: Sixteen (80%) of patients had complete data used in the final analysis. The
median (interquartile range) duration of recording was 38 (12–56) h. Compared to the
esophageal probe, SpotOnTM had a bias of 0.06 ± 0.45◦ C and 95% limits of agreement
of −0.83 to 0.95◦ C. The Pearson correlation coefficient was 0.97 (95% confidence
interval 0.9663–0.9678), with a two-tailed p < 0.0001.
Conclusion and Relevance: The SpotOnTM is an accurate method that may enable
non-invasive monitoring of core body temperature during TTM, although its precision is
slightly worse than the predefined 0.5◦ C when compared to invasive esophageal probe.
Keywords: critical care, heart arrest, hypothermia, induced, brain injuries, thermometers, technology
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INTRODUCTION

employs wider temperature ranges and longer measurement
duration (up to 72 h).
The aim of this study was to assess the accuracy, precision,
and correlation of the SpotOnTM monitor compared to a standard
invasive core body temperature monitor in cardiac arrest patients
undergoing TTM.

Implementation of targeted temperature management (TTM)
protocols is an important component of post-cardiac arrest care
that is associated with improved neurologic outcomes (1, 2).
TTM protocols generally include rapid cooling, maintenance,
rewarming, and hyperthermia prevention stages that are
delivered over 24–72 h following cardiac arrest (3–5). Recent
evidence suggests that targeted normothermia and prevention
of hyperthermia in a subset of patients within the post-cardiac
arrest period may be as effective as hypothermia in improving
post-cardiac arrest outcomes (6). Accurate monitoring of
core body temperature is a critical component of TTM,
and current guidelines recommend using invasive esophageal,
nasopharyngeal, bladder, endotracheal cuff, or pulmonary artery
temperature sensors to achieve this goal (3–5).
A novel temperature monitor (SpotOnTM , 3M, Minnesota,
USA) is an attractive non-invasive alternative for tracking
core body temperature during TTM. SpotOnTM is applied
to the forehead, creates an isothermic tunnel under the
measurement site by insulating heat loss from the skin surface,
and estimates core body temperature using the zero-heat-flux
technology (7). In perioperative settings, SpotOnTM showed
good correlation, accuracy, and precision when compared to
esophageal, nasopharyngeal, and pulmonary artery sensors (8–
10) and was better than bladder temperature sensors (10).
However, these studies only measured temperatures for up to 9 h
and did not compare the SpotOnTM monitor during TTM, which

MATERIALS AND METHODS
Study Design and Patients
This was a prospective observational single-center study that
recruited consecutive patients with cardiac arrest admitted to two
intensive care units (ICUs) at the London Health Sciences Centre
in London, Canada. Inclusion criteria were age ≥18 years with
in- and out-of-hospital cardiac arrest who were eligible for TTM
as per established hospital protocols developed in accordance
with the current practice guidelines (3). Exclusion criteria
were immediate plan to withdraw life-sustaining measures,
inability to obtain consent, skin rash or infection over the
forehead, or medical tape allergy. The study was approved
by the Western University Health Sciences Research Ethics
Board (Protocol # 109432). We obtained signed informed
consent from substitute decision-makers prior to commencing
study procedures.

Study Procedures
Following study enrollment, we initiated simultaneous recording
of the patient’s core body temperatures using SpotOnTM and

FIGURE 1 | Enrolment flow diagram.
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esophageal temperature probes for the duration of the TTM
protocol. The TTM protocol at our hospital included cooling,
maintenance, rewarming, and hyperthermia prevention for up

to 72 h following cardiac arrest. In each patient, we used the
pressure-sensitive adhesive to secure the SpotOnTM temperature
probe to the patient’s forehead as per the product monograph.
We then connected the probe to the SpotOnTM central portable
console and initiated temperature measurement. All patients had
esophageal temperature probes inserted as per our institutional
TTM protocol. We used an automated data capture module
(MediCollector R , USA) to simultaneously record temperatures
from both the SpotOnTM and esophageal temperature probes at
1-min intervals for the duration of the TTM protocol. We used
case report forms for each patient to record demographic data,
type of cardiac arrest, comorbidities, duration of TTM protocol,
and temperature recording from the medical chart.

TABLE 1 | Patient demographics.
Subjects

16

Sex (M:F)

11:5

Age (IQR)

65.5 (54–71.5)

IHCA

7 (43.8%)

OHCA

9 (56.2%)

VT or VF

4 (25%)

PEA or asystole

12 (75%)

Cooling—hours (IQR)
Recording—hours (IQR)

24 (24–24)

Data Analysis and Statistics

38.14 (11.69–56.10)

Statistical analysis was performed using GraphPad Prism version
8.3 (GraphPad Software R , San Diego, CA, USA). Continuous
variables were reported using medians and interquartile ranges
(IQRs) for non-normally distributed data or means and standard
deviations for normally distributed data, and categorical variables
were reported as frequencies (%). The primary endpoint for
this study was accuracy between the SpotOnTM and esophageal
temperature probes, measured as bias using the Bland–Altman
analysis. Secondary outcomes include precision, measured as
limits of agreement using the Bland–Altman analysis, and
correlation, measured using the Pearson correlation coefficient.

Comorbidities
Coronary disease

0 (0%)

Congestive heart failure

3 (18.75%)

Diabetes

5 (31.25%)

Hypertension

9 (56.25%)

Chronic kidney disease

3 (18.75%)

Dyslipidemia

6 (37.5%)

COPD

2 (12.5%)

IQR, interquartile range; IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac
arrest; VT, ventricular tachycardia; VF, ventricular fibrillation; PEA, pulseless electrical
activity; COPD, chronic obstructive pulmonary disease.

FIGURE 2 | Temperature measurement between SpotOnTM and an esophageal probe in a representative patient.
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FIGURE 3 | Bland-Altman analysis comparing SpotOnTM and the esophageal temperature probe.

RESULTS

not able to be detected by the SponOnTM probe. For our
primary outcome (accuracy), the bias measured using the
Bland–Altman analysis was 0.06 ± 0.45◦ C (Figure 3). For
our secondary outcomes, the precision as measured by the
Bland–Altman analysis 95% limits of agreement was −0.83
to 0.95◦ C (Figure 3). The correlation analysis between the
two modalities showed a Pearson coefficient of 0.967 (95%
confidence interval 0.966–0.968), with a two-tailed p < 0.0001
(Figure 4).
Furthermore, we stratified the data to determine the
accuracy and precision of the SpotOnTM temperature probe
across three temperature ranges: normothermia (≥36.0◦ C), mild
hypothermia (34.0–35.9◦ C), and deep hypothermia (<34.0◦ C).
In the normothermia group (≥36.0◦ C), there were 8,226 pairs of
temperature measurements, with a bias of 0.05 ± 0.43◦ C and 95%
limits of agreement of −0.79 to 0.88◦ C. In the mild hypothermia
group (34.0–35.9◦ C), there were 7,417 pairs of temperature
measurements with a bias of 0.03 ± 0.49◦ C and 95% limits
of agreement of 0.93–1.00◦ C. In the deep hypothermia group
(<34.0◦ C), there were 14,107 pairs of temperature measurements
with a bias of 0.09 ± 0.45◦ C and 95% limits of agreement of −0.79
to 0.97◦ C (Figure 5).

We enrolled 20 consecutive patients in the study. Four (20%)
patients had incomplete data due to failure of the recording
equipment and were excluded from data analysis. The remaining
16 patients (5 women) were included in the final analysis
(Figure 1). Their clinical characteristics are summarized in
Table 1. Median (IQR) age was 66 years (54–72) years, 9 (56%)
patients had an out-of-hospital cardiac arrest, 4 (25%) had a
shockable rhythm, 8 (50%) had pulseless electrical activity, and
the three most common comorbidities were hypertension (56%),
dyslipidemia (38%), and diabetes (31%). The median (IQR)
duration of the TTM protocol was 24 (24–24) h and the median
recording time was 38 (12–56) h. Figure 2 shows a sample
recording from a representative patient.
Combining data across all patients with multiple observations
per patient, we had 29,750 sets of data points from the two
temperature probes. All patients within the study underwent
rapid cooling as part of TTM, although their temperature target
varied at the discretion of the treating physician. Temperatures
detected by the esophageal probe ranged from 29.4 to 37.9◦ C.
Within this range, there were no temperatures that were
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FIGURE 4 | Correlation between temperature measurement using SpotOnTM and the esophageal temperature probe.

FIGURE 5 | Bland-Altman analysis comparing SpotOnTM and esophageal temperature probes in different temperature ranges, including deep hypothermia (<34◦ C),
mild hypothermia (34–35.9◦ C), and normothermia (≥36◦ C).

DISCUSSION

for monitoring of core body temperature during TTM (3–5).
However, these monitors are invasive and may not be readily
available in all centers. In this study, we measured the accuracy
and precision of the SpotOnTM against the invasive esophageal
probe in patients undergoing TTM. Our results suggest that the
SpotOnTM monitoring device has an accuracy consistent with
what was acceptable in prior studies (11), although its precision

Targeted temperature management is a fundamental component
of post-cardiac arrest care that relies on accurate and precise
monitoring of core body temperature (3–5). Current guidelines
recommend using esophageal, nasopharyngeal, bladder,
endotracheal cuff, and pulmonary artery temperature sensors

Frontiers in Medicine | www.frontiersin.org
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procedures for our ICU and were confirmed using chest
X-ray. While one study showed that incorrect position of
nasopharyngeal probe placement can affect accuracy of
temperature measurement by approximately 0.2◦ C (17),
confirming accurate placement of our esophageal probes
beyond chest X-ray using modalities, such as CT scanning,
was beyond the standard of care in our patients with postcardiac arrest. Considering these limitations, we chose to use
esophageal probes as a reference standard instead of pulmonary
artery catheters.
Another possible limitation of our study was a small
proportion of outlying data included in our analysis. The main
cause of this was due to dislodgement or detachment of either the
SpotOnTM or the esophageal temperature probe. Unfortunately,
this occurs commonly during routine post-cardiac arrest care
due to nursing care, imaging studies, invasive procedures, and
interventions. Given that we were measuring temperatures every
minute, even a short period of probe dislodgement or detachment
can lead to a sizable number of outliers. However, given that we
had an extensive number of data points, the amount of outlying
data was not likely significant enough to have a substantial impact
on the results. Lastly, shivering may also impact the accuracy
of SpotOnTM measurements, although we did not assess this
specifically in our study.

is just outside the previously accepted 95% limits of agreement
of <0.5◦ C (9).
The SpotOnTM thermometer has acceptable accuracy and
precision for continuous core body temperature monitoring in
perioperative settings (8–10) and during TTM (12, 13). Our work
compliments these studies by providing a larger dataset spanning
broader temperature ranges during TTM (13). Although they
have become standard of care, invasive temperature monitors
still have associated risks. For example, the risks associated
with esophageal probes include vomiting and aspiration, tracheal
misplacement and endotracheal tube cuff leak, and mucosal
injury that can lead to bleeding, especially in patients with postcardiac arrest due to concurrent acidosis, hypothermia, and use
of therapeutic anticoagulation and platelet inhibitors (14). In
contrast, the SpotOnTM monitor is non-invasive and easy to
apply. The only potential drawbacks of the SpotOnTM device
include restrictions with application in patients with adhesive
allergies and potential for skin breakdown with extensive use,
although these adverse events were seen neither in our study nor
in a prior study that used SpotOnTM for the duration of time that
was similar to TTM protocols (13).
An added benefit of the SpotOnTM thermometer is that its
placement over the forehead provides an indirect measure of the
brain temperature. Given that the purpose of TTM is to limit
secondary brain injury by accurately titrating brain temperature,
non-invasive monitoring of brain temperature by the SpotOnTM
thermometer may be more clinically relevant than monitoring of
core body temperature at non-brain sites. In the future, selective
brain cooling while maintaining body normothermia may enable
neurologic benefits of TTM while minimizing systemic side
effects associated with whole-body cooling (15). In these cases,
non-invasive monitoring of brain temperature using SpotOnTM
would be highly relevant.
Our study had several limitations. We enrolled only 20
patients at a single-center and 4 patients were excluded due to
a failure of data recording equipment. While the remaining 16
patients is a small sample size, long duration and high frequency
of temperature recording resulted in a large dataset spanning
a broad range of temperatures, enabling a robust comparison
between the two temperature monitoring modalities. Although
this large dataset of paired measurements derives a significant
statistical power in determining the agreement between the
two devices, one limitation is that our patient sample size
was too small to stratify our results into clinical subgroups.
Future larger studies can assess the accuracy and precision of
the SpotOnTM temperature probe during TTM among clinical
subgroups stratified by age, sex, and body mass index.
While the “gold standard” for temperature monitoring is
considered the pulmonary artery catheter (16), we compared
SpotOnTM performance against the esophageal temperature
probe since pulmonary artery catheters are no longer used
routinely in patients with post-cardiac arrest in our units.
The precision and accuracy of the esophageal temperature
probe relative to the pulmonary artery catheter have been
previously demonstrated in another study (16). The esophageal
temperature probes were placed using standard operating

Frontiers in Medicine | www.frontiersin.org

CONCLUSION
The SpotOnTM monitor is an accurate method for continuous
temperature monitoring in patients with post-cardiac arrest,
although its precision is slightly worse than the predefined 0.5◦ C
when compared to the invasive esophageal probe. This device is
an encouraging alternative to invasive probes for monitoring core
body temperature during targeted temperature management,
but larger studies will be required to confirm this in various
patient populations. Furthermore, the possibility of indirect brain
temperature measurement warrants further investigation.
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